Theratase

Theratase was a specialty biotechnology company focused on the development and manufacture of high-purity enzymes for the diagnostic and pharmaceutical industries. The company was a leading producer of glucose oxidase and horseradish peroxidase, essential components for blood glucose monitoring and clinical chemistry. Beyond diagnostics, Theratase explored therapeutic applications for its enzyme technology, including treatments for gout and wound healing. Headquartered in the United Kingdom, the company operated manufacturing facilities in both the UK and the United States. Theratase was acquired by BBI Holdings in 2006 to strengthen its position in the diagnostic reagents market.